Oxaliplatin with high-dose leucovorin (LV) and 5-Fluorouracil (5FU) 48-hour infusion in pretreated metastatic colorectal cancer (FOLFOX6)

被引：0
|
作者：
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles-Amar, V
Izrael, V
Krulik, M
机构：
[1] Hop St Antoine, GERCOR, F-75012 Paris, France
[2] Hop Tenon, F-75020 Paris, France
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
173P
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [31] A Phase II Study of Oxaliplatin, 5-Fluorouracil, Leucovorin, and High-Dose Capecitabine in Patients With Metastatic Colorectal Cancer
    Lubner, Sam J.
    LoConte, Noelle K.
    Holen, Kyle D.
    Schelman, William
    Thomas, James P.
    Jumonville, Alcee
    Eickhoff, Jens C.
    Seo, Songwon
    Mulkerin, Daniel L.
    CLINICAL COLORECTAL CANCER, 2010, 9 (03) : 157 - 161
  • [32] Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma
    Tournigand, C
    Louvet, C
    deGramont, A
    Lucchi, E
    Seitz, JF
    Mal, F
    Raymond, E
    Cady, J
    Carola, E
    Krulik, M
    CANCER, 1997, 79 (06) : 1094 - 1099
  • [33] Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC)
    Kouroussis, C
    Souglakos, J
    Mavroudis, D
    Papadouris, S
    Kakolyris, S
    Agelaki, S
    Kalbakis, K
    Panopoulos, C
    Vardakis, N
    Sarra, E
    Georgoulias, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (06): : 627 - 631
  • [34] A phase II study with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) in patients with metastatic colorectal cancer
    Destefanis, M
    Dalla Mola, A
    Ostellino, O
    Capello, C
    Milanesi, E
    Grillo, C
    Castiglione, F
    Venturino, A
    Porcile, G
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [35] Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) in patients with advanced or metastatic gastric cancer (A/MGC).
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Bernuzzi, P
    Bertè, R
    Bidin, L
    Palladino, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 330S - 330S
  • [36] Cost-effectiveness analysis of pharmacokinetic-guided (PK) 5-fluorouracil (5FU) when combined with leucovorin and oxaliplatin (FOLFOX) chemotherapy for metastatic colorectal cancer (mCRC)
    Goldstein, Daniel A.
    Chen, Qiushi
    Howard, David H.
    Lipscomb, Joseph
    Ayer, Turgay
    Harvey, Donald
    El-Rayes, Bassel F.
    Flowers, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Intravenous weekly high-dose infusion of 5-fluorouracil and folinic acid in pretreated patients with metastatic colorectal cancer
    Lorenz, M
    StaibSebler, E
    Gog, C
    Petrowsky, H
    Encke, A
    ONKOLOGIE, 1997, 20 (03): : 222 - 225
  • [38] Irinotecan (CPT11) plus high-dose 5-fluorouracil (5-FU) and leucovorin (LV) as salvage therapy for metastatic colorectal cancer (MCRC) after failed oxaliplatin plus 5-FU and LV: a pilot study in Taiwan
    Tai, CJ
    Liu, JH
    Chen, WS
    Lin, JK
    Wang, WS
    Yen, CC
    Chiou, TJ
    Chen, PM
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (03) : 136 - 140
  • [39] HIGH-DOSE LEUCOVORIN (CF), 5-FLUOROURACIL (5-FU) AND CISPLATIN (CIS) CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
    SCHEITHAUER, W
    DEPISCH, D
    SCHIESSEL, R
    ZIELINSKI, C
    PREIS, P
    GISSLINGER, H
    LUDWIG, H
    BLUT, 1988, 57 (04): : 206 - 206
  • [40] Interstitial lung disease in a patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) for metastatic colorectal cancer
    Hannan, Liam M.
    Yoong, Jaclyn
    Chong, Geoffrey
    McDonald, Christine F.
    RADIOLOGY AND ONCOLOGY, 2012, 46 (04) : 360 - 362
12345